Yu-Hung Wang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Blood advances

British journal of haematology

Blood cancer journal

Cancer reports (Hoboken, N.J.)

National Taiwan University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital Aug 01 2014

Taiwan

Dr. :: Internal Medicine

Publications

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology 204 (4) (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology 204 (4) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Kristian Gurashi, Fabio M R Amaral, Hasse Bossenbroek, Andrés Jerez, Tim C P Somervaille, Moritz Binder, Mrinal M Patnaik, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Fabio Amaral, Shan-Chi Yu, Chein-Jun Kao, Pin-Tsen Shih, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes. Blood advances (2023)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Bettina Wingelhofer, Fabio M R Amaral, Chi-Yuan Yao, Hsin Ting Hsieh, Ming Chih Liu, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target. Leukemia (2023)
Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Chi-Ling Chen, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Higher RUNX1 expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patients. EJHaem 3 (4) (2022)
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome. British journal of haematology (2021)
Yu-Hung Wang, Hsin-An Hou, Chien-Chin Lin, Yuan-Yeh Kuo, Chi-Yuan Yao, Chia-Lang Hsu, Mei-Hsuan Tseng, Xavier Cheng-Hong Tsai, Yen-Ling Peng, Chein-Jun Kao, Wen-Chien Chou, Hwei-Fang Tien
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood advances 5 (22) (2021)
Yu-Hung Wang, Feng-Ming Tien, Xavier Cheng-Hong Tsai, Huai-Hsuan Huang, Jia-Hau Liu, Xiu-Wen Liao, Jih-Luh Tang, Ming Yao, Bor-Sheng Ko
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study. Cancer reports (Hoboken, N.J.) (2021)
Yu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, Xavier Cheng-Hong Tsai, Shan-Ju Wu, Hsin-An Hou, Tai-Chung Huang, Yuan-Yeh Kuo, Ming Yao, Koping Chang, Chung-Wu Lin, Yun-Chu Lin, Feng-Ming Tien, Wen-Chien Chou, Jih-Luh Tang, Hwei-Fang Tien
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden. Blood cancer journal 10 (10) (2020)

Yu-Hung Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yu-Hung Wang